First Page | Document Content | |
---|---|---|
Date: 2018-02-25 01:50:36 | XOFLUZATM (Baloxavir Marboxil) Tablets 10mg/20mg Approved for the Treatment of Influenza Types A and B in Japan Osaka, Japan, February 23, Shionogi & Co., Ltd. (Head Office: Osaka; President & CEO: Isao Teshirogi,Add to Reading ListSource URL: isirv.orgDownload Document from Source WebsiteFile Size: 81,08 KBShare Document on Facebook |